Summary
A clinical therapeutic trial of tolmetin in daily doses of 1200 and 1600 mg. is reported in 16 patients with rheumatoid arthritis. The drug was given for a period of 2 weeks at both dose levels. Significant improvement was noted with both dose levels in pain relief, articular tenderness and grip strength, but no significant differences were noted between the two dosages. An anti-inflammatory effect could not be demonstrated. Five of the 16 patients had to discontinue therapy at the lower dose due to gastric intolerance.
Key words: :